We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
+14.38%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$253M
AUM Growth
+$7.33M
Cap. Flow
+$5.92K
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$5.92K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.5%
2 Miscellaneous 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$162M 63.94%
1,111,111
– –
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$46.8M 18.49%
31,841,394
+8,060
+0% +$5.92K
BCRX icon
3
BioCryst Pharmaceuticals
BCRX
$2.52B
$40.7M 16.07%
3,846,154
– –
EPZM
4
CALL
DELISTED
Epizyme, Inc
EPZM
$3.79M 1.5%
2,575,450
+27,166
+1% +$20K
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$18K 0.01%
3,700
– –

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q2 2022 Portfolio in Review

As of Q2 2022, RP Management held 5 positions worth $253M, up 3% from $246M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. RP Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 98% a quarter earlier, followed by Miscellaneous.

  • RP Management added most to Epizyme, Inc in Q2 2022, an estimated $5.92K increase.
  • RP Management's ten largest holdings make up 100% of its $253M portfolio in Q2 2022.
  • RP Management opened 0 new positions and closed 0 in Q2 2022.
  • RP Management's portfolio value rose 3% quarter-over-quarter to $253M.

Based on RP Management's 13F filing for Q2 2022, filed 10 Aug 2022.